1. Regulation of osteoclast-mediated bone resorption by microRNA
   Ling Ji et al, 2022, Cellular and Molecular Life Sciences CrossRef
2. Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis
   Jianbo He et al, 2019, Frontiers in Pharmacology CrossRef
3. Delay the progression of glucocorticoid‐induced osteoporosis: Fraxin targets ferroptosis via the Nrf2/GPX4 pathway
   Xiang Zheng et al, 2024, Phytotherapy Research CrossRef
4. MicroRNAs: Key Regulators to Understand Osteoclast Differentiation?
   Claire Lozano et al, 2019, Frontiers in Immunology CrossRef
5. Icariin Alleviates Glucocorticoid‐Induced Osteoporosis through EphB4/Ephrin‐B2 Axis
   Mi Huang et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
6. Alternative Medical Therapy
   Jawahar Tulsidas Jethwa, 2023, Indian Journal of Orthopaedics CrossRef
7. Identification of circRNA Expression Profiles in BMSCs from Glucocorticoid-Induced Osteoporosis Model
   Zhipeng Chen et al, 2022, Stem Cells International CrossRef
8. Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
   Valeria Fernández Vallone et al, 2023, Frontiers in Oncology CrossRef
9. Lactobacillus plantarum attenuates glucocorticoid-induced osteoporosis by altering the composition of rat gut microbiota and serum metabolic profile
   Siying Li et al, 2024, Frontiers in Immunology CrossRef
10. Icariin Attenuates Amyloid-β (Aβ)-Induced Neuronal Insulin Resistance Through PTEN Downregulation
    Xiaomei Zou et al, 2020, Frontiers in Pharmacology CrossRef
11. MicroRNAs and Osteoporosis
    Xue Wang et al, 2021, Noncoding RNAs and Bone CrossRef
12. Therapeutic approach of natural products that treat osteoporosis by targeting epigenetic modulation
    Guokai Zhang et al, 2023, Frontiers in Genetics CrossRef